|
|
|
| |
■Total participant in 2010 is 258. |
| |
Breakdown By Country |
| |
■ More than 9 countries attended BBA 2010 in Taiwan, such as Australia, China, Germany, HK, Japan, India, Singapore, Taiwan, U.S.A. |
| |
 |
|
| |
■ 258 participants attended 2010 BBA Conference,
countries including as follows: |
 |
 |
|
|
| |
Attendees' Field of Expertise |
| |
 |
Biotechnology |
14% |
MedicalDevices |
5%
|
Novel Therapeutics |
1%
|
Services |
3%
|
Pharmaceuticals |
22%
|
Others |
33%
|
Media |
14%
|
VC |
7%
|
|
|
|
| |
Partnering Objective |
| |
| ■ R&D corporation
: 50% |
| ■ Marketing/ Sales alliance
: 24% |
| ■ Fund raising or Investment
: 15% |
| ■ Other Subject
: 11% |
|
| |
 |
|
| |
Conference Insights |
| |
|
| Johnsee Lee, chairman of the 2010 BBA conference organizing committee and the president of Industrial Technology Research Institute, addressed in the opening ceremony. |
|
|
|
| |
 |
| Giving opening remarks at BioB5usiness Asia 2010
was Dr. Jin-Fu Chang, Minister, The Executive Yuan; and Yen-Shiang Shih, Minister, Ministry of Economic Affairs. |
|
|
|
|
| |
 |
| BioBusiness Asia 2010 Opening Ceremony. The conference aims to serve as a platform to foster international collaboration for biotech industry and to explore opportunities discovering potential partners. Participants from left to right: Yio-Wha Shau, general director of ITRI's Biomedical Technology and Device Research Labs (BDL); Peter Fitzgerald, Director, Center for Cardiovascular Technology, Stanford University; Jin-Fu Chang, Minister, The Executive Yuan; Johnsee Lee, president of the Industrial Technology Research Institute; Yen-Shiang Shih, Minister, Ministry of Economic Affairs ; Ann Hanham, Managing Director, Burrill & Co.; Chung-Cheng Liu, Co-Chair, Conference Organizing Committee, BioBusiness Asia Conference 2010. |
|
 |
| A major international collaboration was announced between two groups of Taiwanese and Malaysian life science companies. The Taiwan group is made up of drug maker China Chemical & Pharmaceutical Co., Ltd., and medical imaging firm New Medical Co., Ltd., The Malaysian group consists of two companies from the Nano Care Medic Group; Nanocare and NMC.These two groups first made contact at BBA 2009 during a business partnering session, and after a year of planning, representatives of the two groups decided to again sign their cooperation agreement at BBA 2010. |
|
|
|
| |
 |
| Investor Forum I, Gateway to Success: Selecting Taiwan as the Place of Listing, the first-day
afternoon session. Pictured from left to right, Guo-Liang Yu, President, Epitomics; Jonas Wang, Chief Operating Officer, StemCyte; Ming-Chu Hsu, Chairperson and CEO, TaiGen Biotechnology; Daniel Chu, Senior Executive Vice President, GreTai Securities Market; Shengwan Lee, General Partner, Pac-Link; Audrey Tseng, Deputy Chairman, PricewaterhouseCoopers Taiwan ; Jo Shen, President, ScinoPharm. |
|
 |
| Participants in BioBusiness Asia 2010. |
|
|
|
| |
|
| The second investor forum examines growing Taiwan-China biotech industry ties and how the business environment has shifted since the recent global economic crisis. This forum will feature Dr. Frank Grams, Executive Director, Roche Global Pharma Partnering, Asia. |
|
|
|
| |
One-on-One Meeting |
| |
| ■ Total presenting company number : 22 |
| ■ Match making company number : 57 |
| ■ Total number of one-on-one meetings: 110 |
|
| |
 |
| One-on-One Meetings were arranged during these two days. |
|
|
|
|
|
|
|
